Real-world Study Comparing the Adherence and Effectiveness of Linagliptin vs. Acarbose
NCT04180813 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 85
Last updated 2022-06-23
Summary
Non-interventional cohort study based on newly collected data under routine medical practice of a total of 500 Diabetes Mellitus, Type 2 patients
Conditions
- Diabetes Mellitus, Type 2
Interventions
- DRUG
-
Linagliptin
drug
- DRUG
-
Acarbose
drug
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-04
- Primary Completion
- 2021-07-11
- Completion
- 2021-07-11
Countries
- China
Study Locations
More Related Trials
-
Study for Beinaglutide Versus Glargine Therapy in Glycemic Variability of Type 2 Diabetes Mellitus
NCT03829891 ·Status: COMPLETED ·Phase: NA
-
Effects of Linagliptin in Addition to Empagliflozin on Islet Cell Physiology
NCT02401880 ·Status: COMPLETED ·Phase: PHASE4
-
Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone
NCT00996658 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Linagliptin (BI 1356) on 24h-glucose Control and Various Biomarkers in Type 2 Diabetic Patients
NCT00716092 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.
NCT01098539 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With Type 2 Diabetes
NCT00954447 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes
NCT00838916 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Linagliptin + Metformin on Patients Who do Not Achieve Normoglucemia With Metformine
NCT04088461 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Lobeglitazone Versus Sitagliptin
NCT02480465 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control
NCT02104804 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes
NCT02008682 ·Status: COMPLETED ·Phase: PHASE4
-
Active Surveillance Research Program for the Assessment of the Safety and the Effectiveness of Linagliptin
NCT02197078 ·Status: COMPLETED
-
Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes
NCT00838903 ·Status: COMPLETED ·Phase: PHASE3
-
Real World Glycemic Effectiveness of Linagliptin
NCT03338803 ·Status: COMPLETED
-
Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus
NCT01652729 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy and Safety Study in Patients With Type 2 Diabetes Mellitus
NCT01608724 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Linagliptin + Metformin vs Metformin Alone in Patients With Prediabetes
NCT03004612 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Tolerability of Saxagliptin add-on Compared to Uptitration of Metformin in Patients With Type 2 Diabetes
NCT01006590 ·Status: COMPLETED ·Phase: PHASE4
-
Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes.
NCT07019012 ·Status: RECRUITING ·Phase: PHASE4
-
Linagliptin Response to OGTT in Prediabetes and Type 2 Diabetes Mellitus
NCT05290506 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)
NCT03175120 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing the Safety, Tolerance, and Efficacy of Various Doses of SK-0403 Versus Placebo and Sitagliptin 100 mg in Patients Not Well-Controlled on Metformin Therapy
NCT01169090 ·Status: COMPLETED ·Phase: PHASE2
-
Teneligliptin Versus Linagliptin in Diabetes Mellitus Type Two Patients
NCT03011177 ·Status: COMPLETED ·Phase: PHASE4
-
Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns
NCT02138097 ·Status: COMPLETED
-
Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes
NCT00518882 ·Status: COMPLETED ·Phase: PHASE3